A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home Treated Conditions Archive for category "Heart Failure (CHF)" (Page 2)
formats

Boston Scientific Defibrillators Receive CE Mark for 10-Year Longevity Projections

  Boston Scientific has received CE Mark approval for increased longevity projections for the INCEPTA™, ENERGEN™, PUNCTUA™, COGNIS® and TELIGEN® implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The longevity projections are based on data submitted to the European authorities and vary for each device dependent on the model type and settings. Projected device

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific Defibrillators Receive CE Mark for 10-Year Longevity Projections  comments 
formats

Boston Scientific Receives CE Mark for RELIANCE® 4-FRONT™ Defibrillation Lead

Boston Scientific has received regulatory approval to market the RELIANCE® 4-FRONT™ lead, its next generation implantable defibrillation lead now available in Europe and Asia.   According to the press release, “The RELIANCE 4-FRONT lead is built upon the demonstrated performance and reliability of the RELIANCE lead platform with design enhancements intended to simplify the implant procedure.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific Receives CE Mark for RELIANCE® 4-FRONT™ Defibrillation Lead  comments 
formats

FDA Approves St. Jude’s Assura™ ICDs That Reduce Inappropriate Shocks

St. Jude Medical today announced FDA approval of its Assura™ portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).The new implantable defibrillators feature SecureSense™ RV Lead Noise Discrimination, an algorithm that expands the St. Jude Medical ShockGuard® Technology and offers advanced sensing options designed to reduce the incidence of inappropriate shocks for patients

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on FDA Approves St. Jude’s Assura™ ICDs That Reduce Inappropriate Shocks  comments 
formats

St. Jude Warns Physicians of Potential Problem with QuickSite and QuickFlex LV CRT Leads

St. Jude announced it is proactively informing physicians about visual observations of externalized conductors on the silicone end of QuickSite® and QuickFlex® Left-Ventricular Leads, used to connect Cardiac Resynchronization Therapy devices to the heart. The announcement noted that there have been no reports of patient injury or loss of therapy due to externalized conductors in

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Warns Physicians of Potential Problem with QuickSite and QuickFlex LV CRT Leads  comments 
formats

St. Jude Medical Announces Clinical Benefits of Quadripolar CRT Pacing at ACC

St. Jude Medical announced that clinical findings on quadripolar pacing will be presented at the 61st Annual Scientific Sessions of the American College of Cardiology (ACC, Chicago, March 24-27 2012). According to St. Jude’s announcement, quadripolar pacing allows physicians the ability to use multisite left-ventricular (LV) pacing.  Studies that examined the role of multisite pacing in improving hemodynamics and

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Medical Announces Clinical Benefits of Quadripolar CRT Pacing at ACC  comments 
formats

iPacemaker Implantable Pacemaker/ICD Database for the iPhone

My friend and colleague Dr. Irit Yaniv alerted me to this iPhone app that was just released.  It is an implantable pacemaker and defibrillator database that, according to its author, displays up to 70 parameters for each model, includes battery and longevity data, and links directly to product manuals.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on iPacemaker Implantable Pacemaker/ICD Database for the iPhone  comments 
formats

Remon Medical’s Implantable Pulmonary Pressure Sensor (1997-2007)

Remon Medical Technologies, Ltd. was founded in 1997 in Caesarea, Israel to develop implantable, wireless pressure sensors. Remon developed an implantable hemodynamic monitor, which allowed on-demand, non-invasive, leadless self-monitoring of pulmonary artery pressure by the patient at home. ImPressure devices were placed in the pulmonary artery, and transmitted pressure readings to a hand-held monitor.  It was hoped that the

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
1 Comment  comments 
formats

Medtronic’s Chronicle Implantable Hemodynamic Monitor for Heart Failure Monitoring

Image Credit: Medtronic The Medtronic Chronicle implantable hemodynamic monitor used a specialized RV lead/sensor.  The device was able to monitor and telemeter: Systolic and diastolic pressure Estimated pulmonary artery diastolic pressure RV dp/dt (positive & negative) Heart rate & activity Core body temperature Continuous remote monitoring

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Medtronic’s Chronicle Implantable Hemodynamic Monitor for Heart Failure Monitoring  comments 
formats

CardioMEMS Miniature Implantable Wireless Sensors

CardioMEMS was founded by Dr. Jay S. Yadav and Dr. Mark G. Allen in Atlanta, GA in 2000 to develop implantable micro-electromechanical sensors to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. The miniature wireless sensors can be delivered through a catheter.  Once in place, they transmit cardiac output, blood

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on CardioMEMS Miniature Implantable Wireless Sensors  comments 
formats

BioControl’s CardioFit System for the Treatment of Heart Failure via Vagus Nerve Stimulation

BioControl Medical, Ltd. was founded in 1999 by Yossi Gross, and is based in Yehud, Israel.  BioControl’s first devices were developed to treat incontinence due to overactive bladder, stress, and interstitial cystitis.  In 2006 American Medical Sytems acquired an exclusive license for the use of the technology in urology, gynecology and other pelvic health applications.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on BioControl’s CardioFit System for the Treatment of Heart Failure via Vagus Nerve Stimulation  comments 
formats

EBR System’s Wireless Pacemaker

EBR Systems, Inc., founded in 2003 and headquartered in Sunnyvale, CA, is developing the WiCS® Wireless Cardiac Stimulation technology to eliminate cardiac pacing leads, historically a major source of complications and reliability issues.  The startup was spun out of research by founder Debra Echt, a former professor of medicine and a cardiologist at Vanderbilt University.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on EBR System’s Wireless Pacemaker  comments 
formats

Enopace Biomedical

Enopace Biomedical Ltd. was founded in 2008 by Yossi Gross in Caesarea, Israel. Very scant details are available besides that it is developing a neuromodulation system to treat patients with congestive heart failure. According to the company, its technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload. From Enopace’s patent

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Enopace Biomedical  comments 
formats

Respicardia’s remedē Implantable Device for the Treatment of Central Sleep Apnea

Respicardia, Inc. (formerly Cardiac Concepts, Inc.) is a privately held medical device company incorporated in 2006. It is located in Minneapolis, Minnesota, USA.  It is developing an implantable system intended to improve the outcomes for Heart Failure patients by developing an implantable stimulation therapy to treat Central Sleep Apnea. The remedē System is an implantable

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Respicardia’s remedē Implantable Device for the Treatment of Central Sleep Apnea  comments 
formats

Angel Medical’s Guardian Implantable Heart Attack Monitor

Angel Medical was founded by Dr. Robert E. Fischell and Dr. David R. Fischell.  The AngelMed Guardian® system is an implantable cardiac device, designed to detect rapid ST segment shifts that may signify major cardiac events, such as coronary artery occlusions caused by life-threatening vulnerable plaque ruptures. Once an ST shift is detected, the system

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Angel Medical’s Guardian Implantable Heart Attack Monitor  comments 
formats

AIMD Companies Founded by Yossi Gross

Yossi Gross (born February 5, 1947) is an Israeli medical device innovator and entrepreneur. His medical-device companies are incubated through Rainbow Medical. Currently, the following companies led by Yossi Gross are focusing on active implantable medical devices: BetaStim, developing a new neurostimulation treatment for diabetes Brainsgate, developing an implantable device for acute stroke treatment and brain

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on AIMD Companies Founded by Yossi Gross  comments